Cookies on this website

We use cookies to ensure that we give you the best experience on our website. If you click 'Accept all cookies' we'll assume that you are happy to receive all cookies and you won't see this message again. If you click 'Reject all non-essential cookies' only necessary cookies providing core functionality such as security, network management, and accessibility will be enabled. Click 'Find out more' for information on how to change your cookie settings.

Accept all cookies Reject all non-essential cookies

June 2016

Prof Kristijan Ramadan, Department of Oncology
Characterization of the SPRTN metalloprotease in DNA-protein crosslinks repair and its potential for cancer therapy

Dr Andrew Protheroe, OUH NHS Foundation Trust
Dr Kilian Huber, SGC
Chemical proteomics to define the kinome of renal cancer and investigate resistance mechanisms to kinase inhibitors

Dr Victor Bolanos-Garcia, Oxford Brookes University
Prof Paul Brennan, SGC
New anticancer therapies through inhibitiion of Anaphase Promoting complex/cyclosome (APC/C) activation by Cdc20

Prof Paul Fairchild, Dunn School of Pathology
Exploiting the epigenetic memory of iPS cells to optimise dendritic cell based vaccinesNew anticancer therapies through inhibitiion of Anaphase Promoting complex/cyclosome (APC/C) activation by Cdc20

Dr Barbara Braden, OUH NHS Foundation Trust
Computer-aided recognition of Barrett’s oesophagus and its early neoplastic changes

Dr Thomas Ashton, Department of Oncology
Study of the anti-malarial, Atovaquone, as an anti-cancer therapeutic

Dr Dimitris Karamitros, MRC Molecular Hematology Unit
Implementation of novel xenotransplantation mouse models for study of human AML LSC

Dr Pavitra Kannan, Dr Benjamin Irving, Department of Oncology
Linking functional MRI with 3D microscopy to assess radiotherapy response in tumour subregions

Prof Deborah Goberdhan, DPAG
Prof Tudor Fulga, WIMM
Proteome and transcriptome of stress-induced cancer exosomes

Dr Ian Gibbs-Seymour, Dunn School of Pathology
Generation of tools to assess a potential new biomarker in breast, ovarian and prostate cancer tissues

Dr Jyothi Menon, Prof Kate Vallis, Department of Oncology
Prof Robert Carlisle, IBME
Ultrasound-responsive nanocomposite hydrogels for treatment of localised chest wall cancer recurrence

Dr Margaret Duffy, Prof Len Seymour, Department of Oncology
Establishing an ex vivo culture platform for slices from freshly-resected human tumours

Dr Jadwiga Nieminuszczy, Department of Oncology
Biochemical characterisation of a novel exonuclease required for homologous recombination as potential target for improving cancer therapy